Fluorescence imaging with cRGD-ZW800-1

eiden University Medical Center, Leiden, the Netherlands0 个研究点目标入组 12 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•1) Patients > 18 years old;
•2) Patients scheduled and eligible for resection because of colorectal carcinoma;
•3) Patients should be capable and willing to give informed consent before study specific procedures;
•4) Screening ECG and clinical laboratory test results are within normal limits, or if any are outside of normal limits they are considered to be clinically insignificant;
•5) The patient has a normal or clinically acceptable medical history, physical examination, and vital signs findings at screening;
•6) Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial.

•Patients will be excluded if any of the criteria below apply:
•1) History of a clinically significant allergy or anaphylactic reactions;
•2) Patients pregnant or breastfeeding, lack of effective contraception in male or female patients with reproductive potential;
•3) Any condition that the investigator considers to be potentially jeopardizing the patients well-being or the study objectives.

发起方

eiden University Medical Center, Leiden, the Netherlands